• Home
  • Biomanufacturing@CBI


treefoilBiomanufacturing@CBI advances technology, training and knowledge networks in biomanufacturing with the overarching goals of assuring safe, timely, and efficient production and delivery of biologic medicines and educating the next generation of leaders in biomanufacturing.

We pursue these goals through a range of activities, including our precompetitive, collaborative consortia, our development of educational programs, and our participation in sponsored research projects.



CBI is the home of two precompetitive consortia, the Biomanufacturing Consortium (BioMAN), and the Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB). The consortia provide a safe haven environment where industry and academia can collaboratively address challenges through focused workshops, pre-competitive projects, and annual summits on timely and topical subjects in biomanufacturing.


Biomanufacturing@CBI research projects focus on biomanufacturing process innovation for production of biologic medicines including monoclonal antibodies, vaccines, and viral vectors. The main research areas include process analytical technologies, biomanufacturing data analytics, advanced process modeling and control, and continuous manufacturing,


Biomanufacturing@CBI has developed a number of biomanufacturing-related educational offerings, including an MIT residential course, an on-line course on the principles of manufacturing protein and antibody drugs, and a short course on vaccine manufacturing offered in conjunction with the University College London. We are co-developing a blended learning course on the principles of cell therapy manufacturing which will combine on-line learning with hands-on training.